Clinical Trial Update: Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating PB-201 in Type 2 diabetes patients with poor glycemic control on metformin monotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PB-201

Snippet

Sponsor: PegBio Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: UNKNOWN